Replies to post #39925 on $heff's $tation of $tocks & $olid DD

[Biorunner]

PLX- Got a starter position at $9.64

[Investor100]

PLX:Protalix BioTherapeutics - Awaiting FDA Decision

(RTTNews) - Israeli biotech firm Protalix BioTherapeutics Inc. (PLX: News ) is only days away from the scheduled US regulatory decision on its investigational gaucher (pronounced Go-shay) drug Taliglucerase Alfa.

Gaucher disease is an inherited genetic disorder, in which patients lack the normal form of glucocerebrosidase, or GCD enzyme that breaks down specific fat molecules. The lack of this enzyme results in the accumulation of fat in liver, spleen and bone marrow. The disease affects about 1 in 100,000 persons in the general population. According to the National Gaucher Foundation, 2,500 Americans suffer from gaucher disease.

http://www.rttnews.com/Content/TopStories.aspx?Id=1555477&SM=1

Investor 100